NodThera Ltd—(private)—has an oral weight-loss drug called NT-0796 in phase-1/2 (the same drug NodThera is developing Parkinson’s): https://www.clinicaltrials.gov/study/NCT06129409 Related links: https://www.nodthera.com/pipeline/ https://www.fiercebiotech.com/research/nodtheras-clinical-nlrp3-inhibitor-almost-matches-wegovy-weight-loss-mice-bonus-heart https://jpet.aspetjournals.org/content/jpet/early/2024/02/08/jpet.123.002013.full.pdf